Menu
About Us
Company Overview
Our Values
Board of Directors
Team
Scientific Advisers
Clinical Advisers
Corporate Directory
Corporate Governance
Pipeline
Clinical Trial
Investor Centre
Welcome
Investor Fact Sheet
ASX Announcements
Reports
Annual Reports
Half Yearly Reports
Quarterly Reports
Top 20 Shareholders
Research Reports
Shareholder Services
Investor FAQs
US Shareholders
Investor Newsletters
Communication
In the News
Presentations
Contact Us
Contact Us
Email Alerts
Investor Centre
Investor Centre
>
ASX Announcements
Welcome
Investor Fact Sheet
ASX Announcements
Reports
Annual Reports
Half Yearly Reports
Quarterly Reports
Top 20 Shareholders
Research Reports
Shareholder Services
Investor FAQs
US Shareholders
Investor Newsletters
ASX Announcements
Filter by Year:
2024
2023
2022
2021
2020
2019
2018
13 May 2024
Notification of cessation of securities - ATX
30 Apr 2024
Quarterly Activities/Appendix 4C Cash Flow Report
24 Apr 2024
Entitlement Offer - Offer Booklet
16 Apr 2024
Proposed issue of securities - ATX
16 Apr 2024
Entitlement Offer Cleansing Statement
16 Apr 2024
Rights Issue Investor Slide Deck
16 Apr 2024
Fully Underwritten 2 for 5 Entitlement Offer to raise $4.27
12 Apr 2024
Trading Halt
10 Apr 2024
AACR Conference Presentation
27 Mar 2024
Update on ACCENT Trial in Pancreatic Cancer
Previous
1
2
3
4
5
6
7
8
Next